FIELD: medicine.
SUBSTANCE: invention can be used for treating secondary glaucoma in posttraumatic aniridia after optical-reconstructive surgeries with an iris-lenticular diaphragm. Performtransscleral cyclophotocoagulation contact transscleral with using a diode laser in continuous mode at wave length 810 nm and exposure time 3.0 sec. If the ciliary body thickness less than 0.54 mm, 6 laser applicates are applied at circle arc 90° in lower section of an eyeball in 1-2 mm from limb, with power of 1.2 W and pulse energy of 3.6 J. If ciliary body thickness is more than 0.54 mm, then applied 8 laser applicates are applied through a circular arc of 120° in lower section of an eyeball in 1-2 mm from limb, with power of 1.6 W and pulse energy of 5.4 J. Formed on 12 o'clock of conjunctival and scleral flaps with uncovering a strip of ciliary body in distal direction from limb. Under the scleral flap in cornea in sclera with needle 26 G formed inlet into anterior chamber in parallel to iris. In the anterior Chamber is 0.2-0.3 ml of 1 % sodium hyaluronate, needle is removed, in formed opening with help of injector micro shunt Ex-PRESS Model p-50 is implanted. Under scleral flap collagen drainage of triangular base is laid distally to micro shunt, in 2 mm from limb drainage top is under sclera in suprachorioidal space and after reduction of scleral flap together with collagen drain tube is fixed with one interrupted suture by centre. On each side of scleral flap in proximal collagen drain tube is interrupted by one sclero-scleral suture, operation is completed by applying of conjunctival suture.
EFFECT: method enables preserving visual functions by recovering the intraocular fluid outflow tract and achieving reliable hypotensive effect.
1 cl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF COMBINED SURGICAL TREATMENT OF SECONDARY GLAUCOMA CAUSED BY EMULSIFICATION OF SILICONE | 2018 |
|
RU2688960C1 |
METHOD OF COMBINED TREATMENT OF SEVERE FORMS OF REFRACTORY GLAUCOMA | 2020 |
|
RU2741373C1 |
METHOD OF COMBINED SURGICAL TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 2018 |
|
RU2688974C1 |
METHOD OF COMBINED TREATMENT OF PRIMARY CLOSED-ANGLE GLAUCOMA | 2020 |
|
RU2741374C1 |
METHOD FOR LASER TREATMENT FOR ADVANCED STAGE OF OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2778971C1 |
METHOD FOR COMBINED SURGICAL TREATMENT OF GLAUCOMA IN COMBINATION WITH CATARACT | 2021 |
|
RU2769820C1 |
METHOD FOR COMBINED TREATMENT OF NEOVASCULAR ANGLE-CLOSURE GLAUCOMA WITH UNDERLYING DIABETIC OR POST-THROMBOTIC MACULAR EDEMA IN PATIENTS WITH RESIDUAL VISION | 2023 |
|
RU2815812C1 |
METHOD OF TREATING SECONDARY GLAUCOMA CAUSED BY SILICONE EMULSIFICATION | 2013 |
|
RU2531133C1 |
METHOD FOR COMBINED TREATMENT OF SECONDARY NEOVASCULAR GLAUCOMA | 2022 |
|
RU2786144C1 |
METHOD OF COMBINED LASER TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA WITH ANY DEGREE OF TRABECULAR PIGMENTATION | 2023 |
|
RU2805396C1 |
Authors
Dates
2016-06-27—Published
2015-05-14—Filed